Aatru Medical, a Cleveland, OH-based maker of a negative pressure surgical incision management system, completed a Series C round of financing of undisclosed amount.
Private investors participated in the round.
The company intends to use the funds for product development through FDA clearance and other near-term initiatives.
Led by Chairman and CEO Timothy Wojciechowski, Aatru is a medical device technology company focused on advancing its NPSIMS™, a disposable, single-use, patented, low-cost NPWT device designed to require no electromechanical pump, battery or canister.
The company recently submitted to the FDA a traditional 510(k) premarket notification application for its first product, NPSIMS™ – Negative Pressure Surgical Incision Management System. The NPSIMS™ product does not have FDA Clearance and is not for sale at this time.